Concepts (53)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA-Binding Proteins | 1 | 2023 | 161 | 0.730 |
Why?
|
| Mutagens | 2 | 2016 | 74 | 0.560 |
Why?
|
| Deoxyguanosine | 2 | 2016 | 36 | 0.490 |
Why?
|
| Breast Neoplasms | 3 | 2023 | 1723 | 0.490 |
Why?
|
| Smoking | 2 | 2015 | 1024 | 0.340 |
Why?
|
| Telomere | 1 | 2023 | 59 | 0.200 |
Why?
|
| SUMO-1 Protein | 1 | 2020 | 16 | 0.170 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2020 | 47 | 0.160 |
Why?
|
| Receptors, Androgen | 1 | 2020 | 144 | 0.150 |
Why?
|
| Endopeptidases | 1 | 2017 | 64 | 0.130 |
Why?
|
| Mammary Glands, Human | 1 | 2017 | 40 | 0.130 |
Why?
|
| Sister Chromatid Exchange | 1 | 2016 | 6 | 0.130 |
Why?
|
| Pyrethrins | 1 | 2016 | 8 | 0.130 |
Why?
|
| beta Catenin | 1 | 2017 | 78 | 0.120 |
Why?
|
| Insecticides | 1 | 2016 | 54 | 0.120 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 165 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2016 | 124 | 0.120 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 78 | 0.120 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 77 | 0.110 |
Why?
|
| Aspirin | 1 | 2016 | 89 | 0.110 |
Why?
|
| Female | 6 | 2023 | 24698 | 0.110 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 458 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 1234 | 0.100 |
Why?
|
| Case-Control Studies | 1 | 2015 | 1285 | 0.090 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2012 | 53 | 0.090 |
Why?
|
| Humans | 7 | 2023 | 43102 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2016 | 1003 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 3156 | 0.080 |
Why?
|
| Signal Transduction | 1 | 2017 | 2157 | 0.070 |
Why?
|
| Adolescent | 2 | 2016 | 6081 | 0.070 |
Why?
|
| Child | 1 | 2015 | 3443 | 0.060 |
Why?
|
| Young Adult | 2 | 2015 | 5080 | 0.060 |
Why?
|
| Adult | 3 | 2016 | 13872 | 0.050 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 290 | 0.040 |
Why?
|
| Male | 2 | 2016 | 23409 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 307 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2017 | 13 | 0.030 |
Why?
|
| Cell Movement | 1 | 2020 | 655 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 152 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2016 | 195 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2017 | 434 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1124 | 0.020 |
Why?
|
| Jordan | 1 | 2012 | 24 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2016 | 1621 | 0.020 |
Why?
|
| Maternal Exposure | 1 | 2012 | 57 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 1455 | 0.020 |
Why?
|
| Family | 1 | 2012 | 195 | 0.020 |
Why?
|
| Urban Population | 1 | 2012 | 374 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2017 | 2676 | 0.020 |
Why?
|
| Attitude to Health | 1 | 2012 | 338 | 0.020 |
Why?
|
| Rural Population | 1 | 2012 | 373 | 0.020 |
Why?
|
| Pregnancy | 1 | 2012 | 1772 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 12222 | 0.010 |
Why?
|